Blue water biotech issues ceo shareholder letter providing update on commercial launch activities

Cincinnati, july 17, 2023 (globe newswire) -- blue water biotech, inc. (“blue water” or the “company”) (nasdaq: bwv), a biotechnology and pharmaceutical company focused on developing and commercializing transformational therapies to address significant health challenges globally, today issued the following letter to shareholders from its chairman and chief executive officer, joseph hernandez.
BWV Ratings Summary
BWV Quant Ranking